Bioniq, a London-based precision health startup, announced the launch of personalised supplements, Bioniq PRO, for customers from all over the world.
The startup will offer customised supplements worldwide using its patented algorithm, leveraging data from more than 40,000 people with over 4 million biochemical data points, the venture said in a media statement.
It claimed that its algorithm now has grown more robust and more precise than ever, and the resulting level of Bioniq personalisation is 200,000 times higher than similar products on the market.
Bioniq’s extensive database for customisation
The company offers the world’s most personalised supplements based on blood tests.
The company said its database has extended across over 40,000 people and 60,000 blood tests that screen for a vast amount of parameters such as cholesterol, hormone levels, insulin count and the presence of microelements like ferritin and copper.
“We possess one of the most genetically diverse and largest biochemical databases, and its analyses are based on questionnaires and proprietary technology,” the statement said.
Consumers from any country in the world can get personalised supplements either by booking a blood test through Bioniq or uploading a recent blood test report.
This data allows Bioniq to get a thorough understanding of the client’s current nutrient status, then identify imbalances and address them by providing a 100 percent tailor-made daily supplement formula, the company said.
Founder and CEO, Vadim Fedotov said identifying real nutrient imbalances and taking a personalised supplement formula to address them can help individuals not only feel better but also perform better and stay healthier over time.
“At Bioniq, we’re taking personalised health to a whole new level,” he said.
The company is backed by some of the leading European investment funds, including HV Capital (DE) and Unbound (UK), Rocket Internet (DE), Porsche Ventures, and others.
The global personalised nutrition and supplements market has witnessed lucrative growth since 2020, and is expected to reach over $131 billion by 2030.
Follow us on
